Residual Serum Monoclonal Protein Predicts Progression-Free Survival in Patients With Previously Untreated Multiple Myeloma
Cancer - United States
doi 10.1002/cncr.24767
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2010
Authors
Publisher
Wiley